The Cold Truth:

Cryopreservation of Final Product in Cell Therapy Manufacturing

Cryopreservation_of_Final_Product_in_Cell_Therapy_Manufacturing.png

While using “fresh” final products (not designed for long-term storage) in cell therapy manufacturing is perfectly acceptable for proof of concept of the cell therapy, as development into late-stage and then commercial production becomes the goal, different constraints arise. This is where cryopreservation of final product becomes an option and, in some cases, even a necessity.

In this eight-page whitepaper you will learn:

  • The benefits of cryopreservation of final product;
  • The risks of cryopreservation; 
  • How to assess these benefits and risks in order to make informed business decisions regarding if-and when- to utilize cryopreserved final product as you work towards developing a commercially viable cell therapy.

Fill out the form to access your whitepaper.

Access Whitepaper: